# OnCo record arjun-balar (person). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/people/arjun-balar/>
  a schema:Person ;
  onco:kind "person" ;
  schema:identifier "arjun-balar" ;
  schema:name "Arjun V. Balar"@en ;
  schema:description "Led KEYNOTE-052 and IMvigor210 cohort 1, establishing first-line immunotherapy for cisplatin-ineligible bladder cancer."@en ;
  schema:url <https://onco.cc/people/arjun-balar/> ;
  schema:dateModified "2026-09-10"^^xsd:date ;
  schema:citation <https://pubmed.ncbi.nlm.nih.gov/?term=Balar%20AV%5BAuthor%5D%20urothelial%20pembrolizumab> ;
  onco:tag "urothelial", "immunotherapy" ;
  schema:jobTitle "Professor of Medicine and Director, Genitourinary Medical Oncology Program, NYU Langone Perlmutter Cancer Center" ;
  onco:cancers <https://onco.cc/cancers/urothelial/> ;
  onco:technologies <https://onco.cc/technologies/checkpoint-inhibitor/> ;
  onco:targets <https://onco.cc/targets/pd1/>, <https://onco.cc/targets/pdl1/> ;
  onco:drugs <https://onco.cc/drugs/pembrolizumab/>, <https://onco.cc/drugs/atezolizumab/> ;
  onco:institutions <https://onco.cc/institutions/nyu-perlmutter/> ;
  schema:affiliation <https://onco.cc/institutions/nyu-perlmutter/> .